Related Experiment Video
Updated: Mar 6, 2026

10:24
Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
6.8K
A hybrid Ornstein-Uhlenbeck-Branching framework unifies microbial and pediatric tumor evolution
1Department of Biology, Fisher College, Boston, MA, United States.
Frontiers in Oncology
|March 5, 2026
Summary
This study introduces a hybrid Ornstein-Uhlenbeck-Branching model to explain tumor relapse dynamics. The model captures how variability and stabilizing forces influence cancer evolution and treatment responses.
Area of Science:
- Evolutionary Biology
- Mathematical Modeling
- Cancer Research
Background:
- Pediatric tumors can relapse even with low mutation burdens, indicating complex evolutionary dynamics.
- Understanding these dynamics requires models that account for both random chance (stochastic variability) and counteracting forces (stabilizing constraints).
Purpose of the Study:
- To develop and validate a novel computational framework, the Ornstein-Uhlenbeck-Branching model, for simulating lineage diversification in evolving populations.
- To apply this model to understand mutation frequency dynamics in bacterial evolution experiments and infer potential applications in cancer research.
Main Methods:
- Developed a hybrid Ornstein-Uhlenbeck-Branching framework combining stochastic trait dynamics with birth-death processes.
- Parameterized the model using data from the *Escherichia coli* long-term evolution experiment (LTEE).
- Conducted forward simulations for predictive modeling and in silico therapy simulations.
Main Results:
- The model accurately reproduced lineage-specific mutation dynamics and branching patterns observed in LTEE.
- Identified distinct evolutionary regimes: high plasticity (priA) and collapse-prone (recG).
- Simulated therapy outcomes, including population dynamics, clonal pruning, and extinction/persistence patterns.
Conclusions:
- The balance between stabilizing forces and stochastic variability quantitatively predicts evolutionary plasticity and persistence.
- The framework offers a foundation for evolution-aware, patient-specific cancer modeling using longitudinal clinical data.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Mutations in Microorganisms
906
Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
906
Cancers Originate from Somatic Mutations in a Single Cell
15.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.2K
Tumor Progression
7.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K
Modern Molecular Taxonomy
786
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
786

